Third, a variety of upstream growth factors, such as epidermal growth factor, VEGF, platelet-derived growth factor-β and transforming growth factor-α, which are generally over-expressed in HCC, can activate this pathway through binding their receptor tyrosine kinases [8,18]. This evidence concerns the gene EGF and hepatocellular carcinoma.